Evidence for the presence and characterization of angiotensin II receptors in rat anterior pituitary membranes

A. Mukherjee, P. Kulkarni, S. M. McCann, A. Negro-Vilar

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Previous work from this laboratory (1) indicates that angiotensin II (AII) can affect release of several anterior pituitary hormones, both in vivo and in vitro. To ascertain whether specific receptors mediate the effects of AII on the anterior pituitary, specific binding as well as the kinetics of [125I] AII binding to rat anterior pituitary membranes were analyzed. Binding of [125I] AII was rapid, reaching equilibrium within 4 min at 37 C. Specific binding was ~90%. Increasing concentrations of ligand resulted in saturation of binding, with equilibrium attained at [125I] AII = 2nM. Scatchard analysis of the data indicated a single class of binding sites, with an equilibrium dissociation constant, Kd = 0.49 nM, and a maximum binding capacity of 40 fmol/mg protein. Specific binding was directly proportional to membrane protein concentration (range 20-240 μg protein). Binding was competitively inhibited on an equimolar basis by (Sar1, Ala8) AII (Saralasin), a specific AII receptor antagonist. The decapeptide Angiotensin I was about 10-20-fold less potent in inhibiting specific AII binding. These studies demonstrate and characterize specific receptor sites for AII in the anterior pituitary gland and offer additional evidence for a role of AII in the regulation of anterior pituitary hormone secretion.

Original languageEnglish (US)
Pages (from-to)665-667
Number of pages3
JournalEndocrinology
Volume110
Issue number2
StatePublished - 1982

Fingerprint

Angiotensin Receptors
Angiotensin II
Membranes
Anterior Pituitary Hormones
Saralasin
Angiotensin I
Anterior Pituitary Gland
Angiotensin Receptor Antagonists
Membrane Proteins
Proteins
Binding Sites
Ligands

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Mukherjee, A., Kulkarni, P., McCann, S. M., & Negro-Vilar, A. (1982). Evidence for the presence and characterization of angiotensin II receptors in rat anterior pituitary membranes. Endocrinology, 110(2), 665-667.

Evidence for the presence and characterization of angiotensin II receptors in rat anterior pituitary membranes. / Mukherjee, A.; Kulkarni, P.; McCann, S. M.; Negro-Vilar, A.

In: Endocrinology, Vol. 110, No. 2, 1982, p. 665-667.

Research output: Contribution to journalArticle

Mukherjee, A, Kulkarni, P, McCann, SM & Negro-Vilar, A 1982, 'Evidence for the presence and characterization of angiotensin II receptors in rat anterior pituitary membranes', Endocrinology, vol. 110, no. 2, pp. 665-667.
Mukherjee, A. ; Kulkarni, P. ; McCann, S. M. ; Negro-Vilar, A. / Evidence for the presence and characterization of angiotensin II receptors in rat anterior pituitary membranes. In: Endocrinology. 1982 ; Vol. 110, No. 2. pp. 665-667.
@article{de2285884eb640a2a9c6fe1c841cf2f4,
title = "Evidence for the presence and characterization of angiotensin II receptors in rat anterior pituitary membranes",
abstract = "Previous work from this laboratory (1) indicates that angiotensin II (AII) can affect release of several anterior pituitary hormones, both in vivo and in vitro. To ascertain whether specific receptors mediate the effects of AII on the anterior pituitary, specific binding as well as the kinetics of [125I] AII binding to rat anterior pituitary membranes were analyzed. Binding of [125I] AII was rapid, reaching equilibrium within 4 min at 37 C. Specific binding was ~90{\%}. Increasing concentrations of ligand resulted in saturation of binding, with equilibrium attained at [125I] AII = 2nM. Scatchard analysis of the data indicated a single class of binding sites, with an equilibrium dissociation constant, Kd = 0.49 nM, and a maximum binding capacity of 40 fmol/mg protein. Specific binding was directly proportional to membrane protein concentration (range 20-240 μg protein). Binding was competitively inhibited on an equimolar basis by (Sar1, Ala8) AII (Saralasin), a specific AII receptor antagonist. The decapeptide Angiotensin I was about 10-20-fold less potent in inhibiting specific AII binding. These studies demonstrate and characterize specific receptor sites for AII in the anterior pituitary gland and offer additional evidence for a role of AII in the regulation of anterior pituitary hormone secretion.",
author = "A. Mukherjee and P. Kulkarni and McCann, {S. M.} and A. Negro-Vilar",
year = "1982",
language = "English (US)",
volume = "110",
pages = "665--667",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Evidence for the presence and characterization of angiotensin II receptors in rat anterior pituitary membranes

AU - Mukherjee, A.

AU - Kulkarni, P.

AU - McCann, S. M.

AU - Negro-Vilar, A.

PY - 1982

Y1 - 1982

N2 - Previous work from this laboratory (1) indicates that angiotensin II (AII) can affect release of several anterior pituitary hormones, both in vivo and in vitro. To ascertain whether specific receptors mediate the effects of AII on the anterior pituitary, specific binding as well as the kinetics of [125I] AII binding to rat anterior pituitary membranes were analyzed. Binding of [125I] AII was rapid, reaching equilibrium within 4 min at 37 C. Specific binding was ~90%. Increasing concentrations of ligand resulted in saturation of binding, with equilibrium attained at [125I] AII = 2nM. Scatchard analysis of the data indicated a single class of binding sites, with an equilibrium dissociation constant, Kd = 0.49 nM, and a maximum binding capacity of 40 fmol/mg protein. Specific binding was directly proportional to membrane protein concentration (range 20-240 μg protein). Binding was competitively inhibited on an equimolar basis by (Sar1, Ala8) AII (Saralasin), a specific AII receptor antagonist. The decapeptide Angiotensin I was about 10-20-fold less potent in inhibiting specific AII binding. These studies demonstrate and characterize specific receptor sites for AII in the anterior pituitary gland and offer additional evidence for a role of AII in the regulation of anterior pituitary hormone secretion.

AB - Previous work from this laboratory (1) indicates that angiotensin II (AII) can affect release of several anterior pituitary hormones, both in vivo and in vitro. To ascertain whether specific receptors mediate the effects of AII on the anterior pituitary, specific binding as well as the kinetics of [125I] AII binding to rat anterior pituitary membranes were analyzed. Binding of [125I] AII was rapid, reaching equilibrium within 4 min at 37 C. Specific binding was ~90%. Increasing concentrations of ligand resulted in saturation of binding, with equilibrium attained at [125I] AII = 2nM. Scatchard analysis of the data indicated a single class of binding sites, with an equilibrium dissociation constant, Kd = 0.49 nM, and a maximum binding capacity of 40 fmol/mg protein. Specific binding was directly proportional to membrane protein concentration (range 20-240 μg protein). Binding was competitively inhibited on an equimolar basis by (Sar1, Ala8) AII (Saralasin), a specific AII receptor antagonist. The decapeptide Angiotensin I was about 10-20-fold less potent in inhibiting specific AII binding. These studies demonstrate and characterize specific receptor sites for AII in the anterior pituitary gland and offer additional evidence for a role of AII in the regulation of anterior pituitary hormone secretion.

UR - http://www.scopus.com/inward/record.url?scp=0020051334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020051334&partnerID=8YFLogxK

M3 - Article

C2 - 6276145

AN - SCOPUS:0020051334

VL - 110

SP - 665

EP - 667

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 2

ER -